Kazia Therapeutics (KZIA) Current Leases (2017 - 2018)
Kazia Therapeutics (KZIA) reported Current Leases of $63591.1 for Q2 2018, up 746.52% on a YoY basis from $7512.1 in Q2 2017, and up 746.52% quarter-over-quarter from $7512.1 in Q2 2017.
Kazia Therapeutics (KZIA) Current Leases (2017 - 2018) Analysis & Trends
Kazia Therapeutics has reported Current Leases for 2 years, with the latest figure at $63591.1 in Q2 2018.
- For the quarter ending Q2 2018, Current Leases rose 746.52% year-over-year to $63591.1; the trailing twelve-month figure through Jun 2018 stood at $63591.1 (up 746.52% YoY), and the FY2018 full-year result was $63591.1, up 746.52% from the prior year.
- Current Leases for Q2 2018 stood at $63591.1, up from $7512.1 in the prior quarter.
- The five-year high for Current Leases was $63591.1 in Q2 2018, with the low at $7512.1 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Kazia Therapeutics | 1.70 Bn | 1.70 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 63,591.10 |
| Jun 30, 2017 | 7,512.10 |